Weighted Average Number of Shares Outstanding, Diluted of Arch Therapeutics, Inc. from 31 Dec 2013 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Arch Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2013 to 30 Jun 2024.
  • Arch Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2024 was 4,444,364, a 247% increase year-over-year.
  • Arch Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 220,001,412, a 17% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Arch Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 4,444,364 +3,164,397 +247% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2024 2024 Q3
Q2 2023 1,279,967 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q3
Q1 2020 186,897,947 +23,276,967 +14% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2020 2020 Q2
Q3 2019 172,575,820 +12,797,655 +8% 01 Jul 2019 30 Sep 2019 10-K 11 Dec 2020 2020 FY
Q2 2019 168,396,553 +17,846,364 +12% 01 Apr 2019 30 Jun 2019 10-K 11 Dec 2020 2020 FY
Q1 2019 163,620,980 +13,318,967 +8.9% 01 Jan 2019 31 Mar 2019 10-K 11 Dec 2020 2020 FY
Q4 2018 161,057,300 -2,469,732 -1.5% 01 Oct 2018 31 Dec 2018 10-K 11 Dec 2020 2020 FY
Q3 2018 159,778,165 01 Jul 2018 30 Sep 2018 10-K 19 Nov 2019 2019 FY
Q2 2018 150,550,189 01 Apr 2018 30 Jun 2018 10-K 19 Nov 2019 2019 FY
Q1 2018 150,302,013 01 Jan 2018 31 Mar 2018 10-K 19 Nov 2019 2019 FY
Q4 2017 163,527,032 +28,207,185 +21% 01 Oct 2017 31 Dec 2017 10-K 19 Nov 2019 2019 FY
Q4 2016 135,319,847 +26,699,272 +25% 01 Oct 2016 31 Dec 2016 10-Q 01 Feb 2018 2018 Q1
Q4 2015 108,620,575 +35,198,568 +48% 01 Oct 2015 31 Dec 2015 10-Q 12 Feb 2016 2016 Q1
Q2 2015 76,804,674 +4,719,926 +6.5% 01 Apr 2015 30 Jun 2015 10-Q 07 Aug 2015 2015 Q3
Q4 2014 73,422,007 +13,276,770 +22% 01 Oct 2014 31 Dec 2014 10-Q 12 Feb 2016 2016 Q1
Q2 2014 72,084,748 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q3
Q4 2013 60,145,237 01 Oct 2013 31 Dec 2013 10-Q 09 Feb 2015 2015 Q1

Arch Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 220,001,412 +31,949,729 +17% 01 Oct 2020 30 Sep 2021 10-K 17 Dec 2021 2021 FY
2020 188,051,683 01 Oct 2019 30 Sep 2020 10-K 17 Dec 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.